NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
Andrew Trout tapped to lead radiology at Cincinnati Children's
October 17, 2025
PET/CT reveals ‘chemo brain’ regions in leukemia patients
October 16, 2025
Nusano, Ariceum Therapeutics sign multi-isotope supply agreement
October 14, 2025